Search News
| 1.07 Delayed Data As of Aug 17 |  -0.06 / -5.31%Today’s Change | 0.98 Today|||52-Week Range 6.96 | -53.88% Year-to-Date |
| Are Options Traders Betting on a Big Move in MannKind (MNKD) Stock? Aug 09 / Zacks.com - Paid Partner Content |
| Previous close | 1.13 |
| Today’s open | 1.12 |
| Day’s range | 1.06 - 1.15 |
| Volume | 1,091,732 |
| Average volume (3 months) | 2,237,391 |
| Market cap | $169.8M |
| Earnings growth (last year) | -183.09% |
| Earnings growth (this year) | +32.74% |
| Earnings growth (next 5 years) | +26.80% |
| Revenue growth (last year) | -93.28% |
| P/E ratio | NM |
| Price/Sales | 20.59 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| OCXOncoCyte Corp | -0.20 | -7.84% |
| BDSIBioDelivery Sciences... | +0.05 | +1.79% |
| OMEDOncoMed Pharmaceutic... | 0.00 | 0.00% |
| CLSDClearside Biomedical... | -0.20 | -2.87% |
| Next reporting date | November 5, 2018 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $11.7M |
| Annual profit (last year) | -$117.3M |
| Net profit margin | -999.00% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Michael E. Castagna |
Chief Financial & Accounting Officer Steven Binder |
Corporate headquarters Westlake Village, California |
